Adipose-derived stem cell treatment for osteoarthritic knees June 21, 2016 Overview Show transcript Overview Jay Smith, M.D., vice chair of Physical Medicine and Rehabilitation at Mayo Clinic, describes a clinical trial to evaluate the safety and efficacy of adipose-derived mesenchymal stromal cell injections as a treatment for patients with osteoarthritic knees. Share Doximity Facebook LinkedIn Twitter Print details Receive Mayo Clinic news in your inbox. Sign up Related ContentArticleMayo researchers prepare to launch clinical trial using gene therapy for knee osteoarthritis Q and AGene therapy for knee osteoarthritis: Q and A with Christopher H. Evans, Ph.D.ArticleCulture-expanded, adipose-derived mesenchymal stem cells tested as treatment for knee osteoarthritis VID-20433303 Medical Professionals Adipose-Derived Stem Cell Treatment for Osteoarthritic Knees